Treatment guidelines for a mildly underactive thyroid gland

April 4, 2017, University of Glasgow
Treatment guidelines for a mildly underactive thyroid gland

Treatment guidelines for a mildly underactive thyroid gland – which affects up to one in then older men and women – are outdated, according to new research.

The study, published today in the New England Journal of Medicine and led by the University of Glasgow – in collaboration with colleagues from the Netherlands, Switzerland, Ireland and Denmark – shows that patients with a mildly (subclinical hypothyroidism) are being prescribed an ineffective medicine.

Under current guidelines, the drug levothyroxine is prescribed to nine of every ten women with the condition and is the most prescribed drug in the US and the third most prescribed drug in the UK.

Subclinical hypothyroidism is a common contributor to many problems in , including causing non-specific symptoms such as tiredness or lethargy, muscle weakness, slowed thought processes, increased and weight and circulation problems.

The five-year European study found that while levothyroxine tablets did effectively restore a normal balance of thyroid function, the treatment provided no apparent symptomatic benefits, with no improvement in muscle strength, speed of thought processes or any effect on body weight or blood pressure.

The authors are calling for a re-evaluation of the guidelines at a presentation at the Endocrine Society Meeting (ENDO 2017) today in Orlando, Florida.

Lead author Professor David Stott, the David Cargill Chair of Geriatric Medicine at the University of Glasgow's Institute of Cardiovascular and Medical Sciences, said: "Our aim is to significantly improve the health and well-being of with subclinical hypothyroidism, by resolving uncertainties about how best to manage this condition.

"Treatment with levothyroxine is common in clinical practice, but controversial. Our study concludes this treatment provides no apparent benefits for older adults and should therefore no longer be started routinely for this condition. An update of the guidelines is necessary."

The study followed 737 older adults (with an average age of 74 years). Half of the in the trial were allocated to a placebo and half to levothyroxine, with participants followed up for at least a year.

Explore further: Cow's milk interferes with absorption of thyroid supplement levothyroxine

More information: David J. Stott et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism, New England Journal of Medicine (2017). DOI: 10.1056/NEJMoa1603825

Related Stories

Cow's milk interferes with absorption of thyroid supplement levothyroxine

April 2, 2017
Taking the common oral thyroid hormone medication levothyroxine with a glass of cow's milk significantly decreases the body's ability to absorb the drug, a preliminary study finds. Results will be presented Sunday at ENDO ...

Patients with heart failure, subclinical hypothyroidism have worse outcomes

April 2, 2017
Patients with more severe heart failure have higher levels of the thyroid hormones TSH and T4 and lower T3 levels, and those with higher T4 levels may be more likely to have atrial fibrillation, new research reports. The ...

Should hypothyroidism in pregnancy be treated?

January 26, 2017
When a woman becomes pregnant, many changes occur in her body. One of those changes is in the levels of various hormones produced by the body.

Multicenter study finds no benefit to treating mild thyroid dysfunction during pregnancy

March 2, 2017
A large national study suggests that treating pregnant women for mildly low thyroid function does not improve the IQs of their babies or reduce preterm births or other negative outcomes.

Giving more pregnant women common thyroid medicine may reduce risk of complications

November 9, 2016
Extending the number of pregnant women given the common drug levothyroxine to boost thyroid hormone levels may lead to a reduced number of stillbirths, early caesarean sections and low-weight babies, according to a new study ...

Opinions vary on management of subclinical hypothyroidism

June 7, 2016
(HealthDay)—Physicians' opinions on management of subclinical hypothyroidism vary, according to a Beyond the Guidelines article published online June 7 in the Annals of Internal Medicine.

Recommended for you

Research finds new mechanism that can cause the spread of deadly infection

April 20, 2018
Scientists at the University of Birmingham have discovered a unique mechanism that drives the spread of a deadly infection.

Selection of a pyrethroid metabolic enzyme CYP9K1 by malaria control activities

April 20, 2018
Researchers from LSTM, with partners from a number of international institutions, have shown the rapid selection of a novel P450 enzyme leading to insecticide resistance in a major malaria vector.

Study predicts 2018 flu vaccine will have 20 percent efficacy

April 19, 2018
A Rice University study predicts that this fall's flu vaccine—a new H3N2 formulation for the first time since 2015—will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the ...

Low-cost anti-hookworm drug boosts female farmers' physical fitness

April 19, 2018
Impoverished female farm workers infected with intestinal parasites known as hookworms saw significant improvements in physical fitness when they were treated with a low-cost deworming drug. The benefits were seen even in ...

Zika presents hot spots in brains of chicken embryos

April 19, 2018
Zika prefers certain "hot spots" in the brains of chicken embryos, offering insight into how brain development is affected by the virus.

Super-superbug clones invade Gulf States

April 18, 2018
A new wave of highly antibiotic resistant superbugs has been found in the Middle East Gulf States, discovered by University of Queensland researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.